MSKPHYSIO.ORG LND LTD

Company Registration Number:
12173899 (England and Wales)

Unaudited statutory accounts for the year ended 31 August 2025

Period of accounts

Start date: 1 September 2024

End date: 31 August 2025

MSKPHYSIO.ORG LND LTD

Contents of the Financial Statements

for the Period Ended 31 August 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

MSKPHYSIO.ORG LND LTD

Directors' report period ended 31 August 2025

The directors present their report with the financial statements of the company for the period ended 31 August 2025

Directors

The director shown below has held office during the whole of the period from
1 September 2024 to 31 August 2025

Alkiviadis Siokos


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
24 February 2026

And signed on behalf of the board by:
Name: Alkiviadis Siokos
Status: Director

MSKPHYSIO.ORG LND LTD

Profit And Loss Account

for the Period Ended 31 August 2025

2025 2024


£

£
Turnover: 0 33
Cost of sales: 0 0
Gross profit(or loss): 0 33
Administrative expenses: ( 7,638 ) ( 9,289 )
Other operating income: 0 0
Operating profit(or loss): (7,638) (9,256)
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: (7,638) (9,256)
Tax: 0
Profit(or loss) for the financial year: (7,638) (9,256)

MSKPHYSIO.ORG LND LTD

Balance sheet

As at 31 August 2025

Notes 2025 2024


£

£
Fixed assets
Intangible assets: 3 0 20,886
Tangible assets: 4 0 3,865
Investments:   0 0
Total fixed assets: 0 24,751
Current assets
Stocks:   0 0
Debtors: 5 0 73
Cash at bank and in hand: 0 929
Investments:   0 0
Total current assets: 0 1,002
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 6 ( 56,732 ) ( 74,846 )
Net current assets (liabilities): (56,732) (73,844)
Total assets less current liabilities: (56,732) ( 49,093)
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): (56,732) (49,093)
Capital and reserves
Called up share capital: 1,000 1,000
Share premium account: 0 0
Other reserves: 0 0
Profit and loss account: (57,732 ) (50,093 )
Total Shareholders' funds: ( 56,732 ) (49,093)

The notes form part of these financial statements

MSKPHYSIO.ORG LND LTD

Balance sheet statements

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 18 February 2026
and signed on behalf of the board by:

Name: Alkiviadis Siokos
Status: Director

The notes form part of these financial statements

MSKPHYSIO.ORG LND LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

    Tangible fixed assets depreciation policy

    Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss. Depreciation Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows: Equipment - 20% reducing balance

    Intangible fixed assets amortisation policy

    Intangible assets Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably. Amortisation Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows: Intangible - 10% straight line. If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

    Valuation information and policy

    Basis of preparation The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

    Other accounting policies

    Impairment of fixed assets A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units. Financial instruments A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

MSKPHYSIO.ORG LND LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 0 0

MSKPHYSIO.ORG LND LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

3. Intangible assets

Goodwill Other Total
Cost £ £ £
At 1 September 2024 0 31,827 31,827
Additions 0 0 0
Disposals 0 ( 31,827 ) ( 31,827 )
Revaluations 0 0 0
Transfers 0 0 0
At 31 August 2025 0 0 0
Amortisation
At 1 September 2024 0 10,941 10,941
Charge for year 0 3,183 3,183
On disposals 0 ( 14,124 ) ( 14,124 )
Other adjustments 0 0 0
At 31 August 2025 0 0 0
Net book value
At 31 August 2025 0 0 0
At 31 August 2024 0 20,886 20,886

MSKPHYSIO.ORG LND LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

4. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 September 2024 6,856 6,856
Additions 684 684
Disposals ( 7,540 ) ( 7,540 )
Revaluations 0 0
Transfers 0 0
At 31 August 2025 0 0
Depreciation
At 1 September 2024 2,991 2,991
Charge for year 910 910
On disposals ( 3,901 ) ( 3,901 )
Other adjustments 0 0
At 31 August 2025 0 0
Net book value
At 31 August 2025 0 0
At 31 August 2024 3,865 3,865

MSKPHYSIO.ORG LND LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

5. Debtors

2025 2024
£ £
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 73
Total 0 73
Debtors due after more than one year: 0 0

MSKPHYSIO.ORG LND LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

6. Creditors: amounts falling due within one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 0 970
Other creditors 56,732 73,876
Total 56,732 74,846